{"id":"https://genegraph.clinicalgenome.org/r/a0474046-28c2-4883-ac33-90c6d7bfb2d5v1.0","type":"EvidenceStrengthAssertion","dc:description":"The *CDH11* gene located on chromsome 16 at 16q21 encodes a type II classical cadherin from the cadherin superfamily, integral membrane proteins that mediate calcium-dependent cell-cell adhesion. The protein is composed of 5 extracellular cadherin domains, one transmembrane domain, and one intracellular domain (Harms 2018). *CDH11* was first reported in relation to Teebi hypertelorism syndrome 2 (TBHS2), also known as brachycephalofrontonasal dysplasia, in 2021 (Li et al., 2021 PMID: 33811546). TBHS2 is characterized by hypertelorism, cardiac and genitourinary defects. Intellectual disability and other craniofacial dysmorphism tends to be rarer and milder than the autosomal recessive condition also caused by variants in *CDH11*, Elsahy-Waters syndrome (ESWS; OMIM:211380).  Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanisms, inheritance patterns, and phenotypic variability among individuals with biallelic versus monoallelic *CDH11* variants. Therefore, the following disease entities have been split into multiple disease entities, AR Elsahy-Waters syndrome (ESWS) (OMIM:211380), and AD Teebi hypertelorism syndrome 2 (OMIM:619736). The split curation for AR Elsahy-Waters syndrome (ESWS) (OMIM:211380) has been curated separately. Other presenting features of TBHS2  include broad or short phalanx, large anterior fontanelle, and umbilical defects. All variants reported to date are missense variants impacting the extracellular domains. Ten probands (6 de novo, 4 consistent with AD inheritance) from two publications are included in this curation (Li 2021, PMID: 33811546; Kuroda 2024, PMID: 37646430). The mechanism of pathogenicity is unclear. This gene-disease relationship is also supported by experimental evidence including mouse models which partially recapitulate the TBHS2 phenotype, particularly with respect to cranial dysmorphology and cardiac defects (Alimperti et al., 2014 PMID: 24741067; Bowen et al., 2015 PMID: 26188246), but these present an inheritance mismatch and likely a molecular mechanism mismatch between homozygous null mice and heterozygous missense human patients. Missense functional alterations in patient fibroblasts show higher *CDH11* expression than wild type controls , and transfected L cells with missense changes found in patients display adhesion and migration defects, suggesting a possible gain of function or dominant negative molecular mechanism of pathogenicity ( PMID: 33811546). In summary, there is moderate evidence supporting the relationship between *CDH11* and AD TBHS2. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date May 17th, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a0474046-28c2-4883-ac33-90c6d7bfb2d5","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d159047f-2ee5-4406-8def-c5fe63b7ffe8","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d159047f-2ee5-4406-8def-c5fe63b7ffe8_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-09-26T14:57:26.377Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/d159047f-2ee5-4406-8def-c5fe63b7ffe8_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-05-17T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d159047f-2ee5-4406-8def-c5fe63b7ffe8_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68a9df7e-fcca-435f-abe1-007b7d9cf0d2","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68a9df7e-fcca-435f-abe1-007b7d9cf0d2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Figure 5a: Cell-to-substrate adhesion assay shows L cells expressing each of five CDH11 mutants to have consistently reduced trans adhesion at the hCadherin-11-Fc amount of 187.5, 375, and 750 ng.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/68a9df7e-fcca-435f-abe1-007b7d9cf0d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","allele":{"id":"https://genegraph.clinicalgenome.org/r/f72a404c-caa7-496c-988e-2a61469e4060","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001797.4(CDH11):c.164G>C (p.Trp55Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396525326"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0b67b92e-7a5d-40a3-b255-fe5f07770dc5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b67b92e-7a5d-40a3-b255-fe5f07770dc5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a19cd4f-1437-49d3-8055-3673e8a13df5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001797.4(CDH11):c.780T>A (p.Asp260Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396522582"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9ff2fec2-c7c0-48bc-9b9b-1a15a9281eb9","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ff2fec2-c7c0-48bc-9b9b-1a15a9281eb9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Figure 5B, C show morphological alteration of fibroblasts from individual 12 (Kindred G) with the p.(Glu279Gln) variant (Indi. 12) as compared to control cells (CTR). Peripheral blebs and ruffles and lack of stress fibers and lamellipodia in Indi. 12 compared to control\n\nC) Abundance of immature focal adhesions not associated to actin stress fibers in Indi. 12 (Glu279Gln) compared to control.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9ff2fec2-c7c0-48bc-9b9b-1a15a9281eb9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","allele":{"id":"https://genegraph.clinicalgenome.org/r/ee443d61-4d28-4fe8-88d7-d281ef6f0f4a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001797.4(CDH11):c.835G>C (p.Glu279Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396522448"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f659b0ce-584d-492f-9ceb-a7e64af0d432","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f659b0ce-584d-492f-9ceb-a7e64af0d432_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Figure 5a: Cell-to-substrate adhesion assay shows L cells expressing each of five CDH11 mutants to have consistently reduced trans adhesion at the hCadherin-11-Fc amount of 187.5, 375, and 750 ng.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f659b0ce-584d-492f-9ceb-a7e64af0d432_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a5dfe27-ae0e-4db8-b740-b9a9b91dd24b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001797.4(CDH11):c.418G>A (p.Glu140Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396523503"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d159047f-2ee5-4406-8def-c5fe63b7ffe8_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dad048ca-76c0-455a-bb5d-a8829fa2205a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","rdfs:label":"Li 2021 Family A","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/dad048ca-76c0-455a-bb5d-a8829fa2205a","type":"Family","rdfs:label":"Li 2021 Family A","member":{"id":"https://genegraph.clinicalgenome.org/r/a074cf38-79eb-4167-bff9-1a0840cb1ddf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","rdfs:label":"Li 2021 Family A Individual 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/24afea80-aab6-45a6-bb31-eb23db642ab1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001797.4(CDH11):c.979G>T (p.Gly327Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396522133"}},"firstTestingMethod":"Exome sequencing","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/30fb8138-7795-4e3d-9565-327e55749342_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","allele":{"id":"https://genegraph.clinicalgenome.org/r/24afea80-aab6-45a6-bb31-eb23db642ab1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a074cf38-79eb-4167-bff9-1a0840cb1ddf"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/3c1a3906-525a-4c7c-adc7-dadcae8885cd_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","rdfs:label":"Li 2021 Family H","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/3c1a3906-525a-4c7c-adc7-dadcae8885cd","type":"Family","rdfs:label":"Li 2021 Family H","member":{"id":"https://genegraph.clinicalgenome.org/r/3b771253-b8e5-41cc-9349-53cecdc5d30d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","rdfs:label":"Li 2021 Family H Individual 16 IV-5","allele":{"id":"https://genegraph.clinicalgenome.org/r/24afea80-aab6-45a6-bb31-eb23db642ab1"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5adf2109-5f8c-4f56-a3df-b052e2ad2950_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","allele":{"id":"https://genegraph.clinicalgenome.org/r/24afea80-aab6-45a6-bb31-eb23db642ab1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":6,"proband":{"id":"https://genegraph.clinicalgenome.org/r/3b771253-b8e5-41cc-9349-53cecdc5d30d"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/dd891e66-37e4-4b33-adc5-b1124a343fe2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","rdfs:label":"Li 2021 Family F","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/dd891e66-37e4-4b33-adc5-b1124a343fe2","type":"Family","rdfs:label":"Li 2021 Family F","member":{"id":"https://genegraph.clinicalgenome.org/r/de010fd0-b265-4f1c-b6e3-c187a1433570","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","rdfs:label":"Li 2021 Family F Individual 8 III-1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8dbe9eb4-ead0-4178-8f01-a69faf0d93c7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001797.4(CDH11):c.778G>A (p.Asp260Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396522587"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Dx: TBHS2 in 4yo male with hypertelorism, proptosis, broad forehead, thick eyebrows, short nose, broad nasal tip, thin upper lip, small chin,, high palate, small teeth, broad toes, ADHD","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e332ebbe-3776-40e8-b8db-0be7029d2da5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","allele":{"id":"https://genegraph.clinicalgenome.org/r/8dbe9eb4-ead0-4178-8f01-a69faf0d93c7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/de010fd0-b265-4f1c-b6e3-c187a1433570"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5adf2109-5f8c-4f56-a3df-b052e2ad2950","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5adf2109-5f8c-4f56-a3df-b052e2ad2950_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cells expressing each of five CDH11 mutants have consistently reduced trans adhesion (Fig 5a)\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/5adf2109-5f8c-4f56-a3df-b052e2ad2950_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3403e4bf-2a03-414e-85db-a605831b0c13","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3403e4bf-2a03-414e-85db-a605831b0c13_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Figure 5a: Cells expressing each of five CDH11 mutants have consistently reduced trans adhesion","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3403e4bf-2a03-414e-85db-a605831b0c13_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","allele":{"id":"https://genegraph.clinicalgenome.org/r/1b8df612-1dc3-42a7-b866-47437b91b734","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001797.4(CDH11):c.785A>T (p.Asn262Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396522569"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/80546038-70d1-4554-b34f-017f54397a62","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80546038-70d1-4554-b34f-017f54397a62_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37646430","allele":{"id":"https://genegraph.clinicalgenome.org/r/e3fec2dc-34c6-46d5-8290-d0746ae1dbe3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001797.4(CDH11):c.229C>T (p.Leu77Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396524333"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/30fb8138-7795-4e3d-9565-327e55749342","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30fb8138-7795-4e3d-9565-327e55749342_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Cells expressing five CDH11 mutants have consistently reduced trans adhesion (Fig 5a)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/30fb8138-7795-4e3d-9565-327e55749342_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e332ebbe-3776-40e8-b8db-0be7029d2da5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e332ebbe-3776-40e8-b8db-0be7029d2da5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Fig 5a: Cells expressing each of five CDH11 mutants have consistently reduced trans adhesion","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e332ebbe-3776-40e8-b8db-0be7029d2da5_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/86840dbe-2113-47e7-9663-93c12b2a4a59","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86840dbe-2113-47e7-9663-93c12b2a4a59_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e7c2d48-d9dc-4ef8-aab8-3c9e6c5e38a1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001797.4(CDH11):c.797C>T (p.Pro266Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA396522541"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8.1},{"id":"https://genegraph.clinicalgenome.org/r/d159047f-2ee5-4406-8def-c5fe63b7ffe8_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d159047f-2ee5-4406-8def-c5fe63b7ffe8_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40da207a-0918-4a5e-b956-81d89186ca47","type":"EvidenceLine","dc:description":"Inheritance mismatch between AR homozygous KO mouse and human het AD condition","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/289e6e00-755b-48fa-89ea-4a65226b0393","type":"Finding","dc:description":"Partially recapitulates human phenotype including craniofacial and genitourinary defects","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27626380","rdfs:label":"Dickinson IMPC db CDH11-/- Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d0029be5-4590-4919-b519-5756b74aa45a","type":"EvidenceLine","dc:description":"Inheritance mismatch between mouse and human","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae970c75-5aa0-437e-baf1-4e75d9cde0b6","type":"Finding","dc:description":"Cdh11-/- mice lack SMC proteins and contractile function in vascular and urinary tissues compared to controls. Note that genitourinary and heart defects are both presenting phenotypes of the AD condition.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24741067","rdfs:label":"Alimperti CDH11 -/- mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/be43b126-81c0-4631-b0a0-939136240901","type":"EvidenceLine","dc:description":"Inheritance mismatch between mouse and human","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6845e7b1-cf55-4014-ae06-3294582cc7b9","type":"Finding","dc:description":"Partial recapitulation of heart valve defects","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26188246","rdfs:label":"Bowen 2015 Cdh11-/- mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d159047f-2ee5-4406-8def-c5fe63b7ffe8_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd35f046-71fb-4d93-8556-ccbf92ab1c0b","type":"EvidenceLine","dc:description":"Already scoring under proband variants","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec1400c6-3042-48ed-97e0-8c8bd4c62044","type":"FunctionalAlteration","dc:description":"Fig 5a","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","rdfs:label":"Li 2021 Fig 5a"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d159047f-2ee5-4406-8def-c5fe63b7ffe8_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a444d68-6202-4dd6-8bcf-5adfd7f36e2b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b4a6b6a-a3e1-4b3e-9969-2b9fb64acbba","type":"Finding","dc:description":"Histological staining of CDH11","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","rdfs:label":"Li 2021 Fetal expression ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e6b227d6-a5aa-479e-a8d3-e12e59b8cd51","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9fc595c0-40a5-493a-9f89-210bc408b84f","type":"Finding","dc:description":"Individual 12 (with CDH11 p.Glu279Gln) shows increased CDH11 expression compared to control by A) immunostaining and B) Western blot\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33811546","rdfs:label":"Li 2021 Fig S4","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Moderate","sequence":9039,"specifiedBy":"GeneValidityCriteria10","strengthScore":10.1,"subject":{"id":"https://genegraph.clinicalgenome.org/r/MnHuAhUYF7A","type":"GeneValidityProposition","disease":"obo:MONDO_0030674","gene":"hgnc:1750","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d159047f-2ee5-4406-8def-c5fe63b7ffe8-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}